-
Q&A
Facing the CriticsRoger Ebert finds peace with his appearance following disfiguring cancer surgery.
by Ronni Gordon
-
Forward Look
The Dense Breast DebateSome states are mandating that doctors tell patients about breast density, which can affect cancer risk.
by Mitzi Baker
-
The Survival GapIn the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?
by Charlotte Huff
-
-
Your Cancer Guide
Giving Kids With Cancer What They NeedSupport should include love, normalcy and age-appropriate information.
by Hester Hill Schnipper
-
Forward Look
Age-Old ConditionProstate cancer is diagnosed in an ancient Egyptian mummy.
by Yvonne Lee
-
Forward Look
When Is “Cancer” Not Cancer?Does the word “cancer” discourage patients with very early disease from fully considering all their options?
by Stephen Ornes
-
Get Involved
One Survivor Making a DifferenceA prostate cancer survivor becomes an advocate for cancer patients.
by Yvonne Lee
-
Forward Look
Therapy Unexpectedly Leads to Mental HazeResearchers surprised that radiation may cause “chemobrain.”
by Melissa Weber
-
The HPV Cancer Connection: Take 2New insights about HPV's role in multiple cancers are rapidly expanding, as are thoughts about who should be vaccinated against the virus, and why.
by Alanna Kennedy-Gorman
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
